February 26, 2024
GLP-1s are drugs proven to treat diabetes. But with high costs, increased use for other purposes and clinical uncertainty, GLP-1s are not without controversy. This brief underscores the history of these medications and makes policy recommendations to ensure patients are receiving the right drugs at the right time.
New from ACHP:
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
- ACHP Letter to Dr. Oz on Deregulation in Health Insurance
- ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule
- ACHP Statement on CY2026 MA and Part D Rate Notice
- ACHP Statement on Final CY2026 MA and Part D Rule
